Built on talent, technology, and trust, Grace is a leading global supplier of specialty chemicals within the Standard Industries family of companies.
Our two industry-leading business segments—Catalysts Technologies and Materials Technologies—provide innovative products, technologies, and services that enhance the products and processes of our customers around the world.
Through customer-driven innovation, strategic acquisitions, flexible worldwide manufacturing, and the talent of our people, we maintain strong strategic positions and unmatched customer relationships with many of the world’s best companies. Over 80 percent of our sales were in segments where we are #1 or #2.
Grace, a Standard Industries company, is committed to delivering value, safely and sustainably, to customers, to shareholders, and to the communities in which we operate.
No. 1 World Market Share
- FCC catalysts
- Independent polypropylene process technology licensing
- Polyolefin catalysts
- Specialty silica gel
* 2019 Sales
** Unconsolidated ART® Hydroprocessing Catalysts joint venture
ART® Hydroprocessing Catalysts
Our ART® Hydroprocessing catalysts technologies, provided through our joint venture with Chevron, are in high demand as the world moves to cleaner-burning fuels. A world-scale, state-of-the-art hydroprocessing catalysts manufacturing facility in our Lake Charles, LA complex opened in 2020.
FCC Catalysts and Additives
Our Fluid Catalytic Cracking (FCC) catalyst customers—world-class refiners delivering fuels and petrochemical feedstocks— value Grace innovation as they seek to maximize their profitability, meet their sustainability objectives, and adjust their product mix to meet the demands of today and tomorrow.
A global leader in specialty silica, our Materials Technologies business delivers silica-based and silica-alumina-based materials to world-class companies to improve their products and processes. In 2021, Grace expanded its Materials Technologies business with the acquisition of the Fine Chemistry Services business previously operated by Albemarle. The acquisition positions Grace as a leading CDMO in North America with complementary expertise at three facilities from coast to coast to support customized development of APIs, cGMP intermediates, and RSMs.